--- title: News/Publications | FDA description: FDA | The latest updates on drug candidate KM-819 --- [![FAScinate-Logo](https://www.fascinatetherapeutics.com/hs-fs/hubfs/FAScinate-Logo.png?width=995&height=296&name=FAScinate-Logo.png "FAScinate-Logo")](http://fascinatetherapeutics.com) English Search - [About Us](https://www.fascinatetherapeutics.com/about-us) - [Product Overview](https://www.fascinatetherapeutics.com/product-overview) - [Partnerships](https://www.fascinatetherapeutics.com/partnerships) - [News/Publications](https://www.fascinatetherapeutics.com/news) # Posts about FDA ## The latest updates on drug candidate KM-819. ##### FAScinate Therapeutics, Inc. Cleared for Phase 2 Clinical Trials of Company’s Parkinson’s Disease Treatment with Approval from U.S. Food and Drug Administration[Read Now >](https://www.fascinatetherapeutics.com/news/fascinate-therapeutics-inc.-cleared-for-phase-2-clinical-trials-of-companys-parkinsons-disease-treatment-with-approval-from-u.s.-food-and-drug-administration-1) *Tuesday, November 23, 2021 / BioSpace* ##### FDA Approval Sought to Begin Phase 2 Trial of KM-819[Read Now >](https://www.fascinatetherapeutics.com/news/fda-approval-sought-to-begin-phase-2-trial-of-km-819) *Wednesday, November 17, 2021 / Parkinson's News Today* [![footer-logo](https://www.fascinatetherapeutics.com/hs-fs/hubfs/footer-logo.png?width=996&height=297&name=footer-logo.png "footer-logo")](https://www.fascinatetherapeutics.com/) ##### Quick Links - [Product Overview](https://www.fascinatetherapeutics.com/product-overview) - [About Us](https://www.fascinatetherapeutics.com/about-us) - [Partnerships](https://www.fascinatetherapeutics.com/partnerships) - [News](https://www.fascinatetherapeutics.com/news) #### Contact Us FAScinate Therapeutics 4365 Executive Dr. Ste. 660 San Diego, CA 92121 [(858) 630-8540](tel:+18586308540) [contact@fascinatetherapeutics.com](mailto:contact@fascinatetherapeutics.com) © FAScinate Therapeutics 2026 | All rights reserved.